SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech firesales
An SI Board Since August 2001
Posts SubjectMarks Bans
3661 167 0
Emcee:  dalroi Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3386EPRS -47% on probable bankruptcy filing: siliconinvestor.comDewDiligence_on_SI-7/5/2016
3385Galena's stops late-stage study of NeuVax in breast cancer due to lack of efJulius Wong-6/29/2016
3384RGLS on FDA clinical hold of RG-101: siliconinvestor.comDewDiligence_on_SI-6/27/2016
3383INFI eviscerated. phx.corporate-ir.netnigel bates-6/14/2016
3382RVNC drops RT001 topical product after phase-3 failure—devotes all resources to DewDiligence_on_SI-6/13/2016
3381Nice AGN call, Miljenko. I had picked up a little but sold it for a modest profiMonkie-6/7/2016
3380ProNAi Therapeutics' stock (DNAI) plunges toward record low after disappointJulius Wong-6/6/2016
3379Ovascience's stock plunges after share offering prices at steep discount maJulius Wong-5/26/2016
3378Ionis Pharmaceuticals Provides Update on IONIS-TTR Rx Program finance.yahoo.comJulius Wong-5/26/2016
3377Ionis Pharmaceuticals (NASDAQ: IONS) reports that strategic alliance partner GlJulius Wong-5/26/2016
3376Aduro Biotech Announces Phase 2b ECLIPSE Trial Misses Primary Endpoint in HeavilJulius Wong-5/16/2016
3375NewLink Genetics (NLNK) off 35% AH on P3 failure in pancreatic cancer. I dontuck-5/9/2016
3374Sorrento (SRNE) of ~16% on activist shareholder scuffle. Asking for firing of Ctuck-5/6/2016
3373Maybe "Something unfortunate" is going on @AGN. That said bought portiMiljenko Zuanic-5/5/2016
3372BERKELEY, CA--(Marketwired - April 27, 2016) - Dynavax Technologies CorporationJulius Wong-4/27/2016
3371Sarepta off 54% premarket Fresh off a negative Ad Comm vote, Sarepta TherapeuticJulius Wong-4/26/2016
3370FDA Still Negative on Sarepta's DMD Drug, Stock Price Sinks thestreet.comJulius Wong-4/21/2016
3369I thnk cash near $6. Yikes.Robohogs-4/18/2016
3368Chiasma down 56% premarket on FDA rejection of Mycapssa NDA It's going to bJulius Wong-4/18/2016
3367Hope FTC will not come up with some unforeseen requirements. fiercepharma.comMiljenko Zuanic-4/14/2016
3366Not that I know of.DewDiligence_on_SI-4/14/2016
3365TEVA already have large pay-for-delay settlement with FTC, so is there problemsMiljenko Zuanic-4/14/2016
3364EU is generally tougher than FTC wrt merger-related divestitures.DewDiligence_on_SI-4/14/2016
3363How tough is the FTC with regards to antitrust in comparison with EU authoritiessemi_infinite -4/14/2016
3362TEVA will certainly not pull out voluntarily. The only concern is FTC approval.DewDiligence_on_SI-4/14/2016
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News